ARA-290 10MG
ARA-290 is a high-purity EPO-derived research peptide designed to activate tissue-protective and anti-inflammatory pathways without stimulating erythropoiesis.
It is widely used in inflammation, neuropathy, and cellular repair research models.
Supplied as a ≥98% HPLC-verified lyophilized peptide for laboratory use only.
$55.00
Satisfaction Guaranteed
Secure
Payment
Third-party
Tested
⚠️ RESEARCH USE ONLY
This product is for R&D purposes only and is not approved for human or veterinary use.
ARA-290 – Non-Hematopoietic EPO-Derived Peptide for Cellular Protection Research
Quantum Biogenix presents research-grade ARA-290, a synthetic peptide derived from erythropoietin (EPO), designed to selectively activate tissue-protective pathways without stimulating erythropoiesis. ARA-290 is widely utilized in inflammation, neuropathy, and tissue repair research models.
ARA-290 targets the innate repair receptor (IRR), a heteromeric receptor complex involved in cellular stress response, inflammation modulation, and tissue protection. Unlike native EPO, ARA-290 does not affect red blood cell production, making it a valuable tool for studying cytoprotective mechanisms without hematologic side effects.
| Product Name | ARA-290 |
| Category | EPO-Derived Research Peptide |
| Form | Lyophilized Peptide Powder |
| Purity | ≥98% HPLC Verified |
| Application | Inflammation, Neuropathy & Tissue Protection Research |
| Usage | Laboratory Research Only |
Scientific Overview of ARA-290
- Non-hematopoietic derivative of erythropoietin (EPO)
- Selective activation of the innate repair receptor (IRR)
- Modulates inflammatory signaling pathways
- Supports cellular protection and tissue repair studies
- High
Reviews
There are no reviews yet.